中恒集团：控股子公司获得药品注册证书

Core Viewpoint - Zhongheng Group's subsidiary, Chongqing Laimei Pharmaceutical Co., Ltd., has received drug registration certificates for two products, which will enhance the company's product line [1] Group 1 - The approved drugs are Nicardipine Tablets (5mg) and Ketorolac Tromethamine Injection (1ml:30mg) [1] - The approval from the National Medical Products Administration is a significant milestone for the company [1] - The addition of these products is expected to contribute positively to the company's growth and market presence [1]